No profile data available.
Alfresa Holdings Corporation (ARHCF) is a healthcare company in the bulk drug suppliers industry, based in Chiyoda, Japan, with about 12,525 full-time employees.
It reported revenue of 2.96 trillion JPY for fiscal year 2025, and net income of 27.39 billion JPY. Its market capitalization was $2.46 billion as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2025; market data as of October 8, 2026.
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally.
Alfresa Holdings reported 2.96 trillion JPY in revenue for fiscal year 2025.
$2.46 billion as of October 8, 2026.
Listed companies of a similar size in the same industry (bulk drug suppliers) include Cosmos Health Inc. (COSM), 111, Inc. (YI), China Medicine Corporation (CHME), Ridgetech, Inc. (RDGT).